Didn't find a medicine?Whatsapp Us!
Molnupiravir (200mg) • 200 mg
Inclusive of all applicable taxes
Fast Delivery
Delivery time confirmed at checkout for your pin code.
Molvrio 200mg Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults. It prevents the virus from multiplying, thereby reducing viral load and disease severity. The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021.Molvrio 200mg Capsule is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms. The risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases. It is not indicated in patients who require immediate hospitalization due to COVID-19. This drug has also been approved by the U.S. Food and Drug Administration (FDA) and the UK regulatory agency for emergency use.Molvrio 200mg Capsule should be taken orally for no longer than 5 consecutive days. It is important to complete the entire 5 days of treatment, therefore do not stop taking it even if you feel better. The medicine may cause dizziness, headache, diarrhea, and nausea in some patients. If one experiences any such side effects, discuss them with the doctor. They may help with the treatment or suggest ways to prevent them.Before taking Molvrio 200mg Capsule, let the doctor know if you have any pre-existing medical conditions. To make sure it is safe for you, inform your doctor about all the other medications you are taking. The use of Molvrio 200mg Capsule is not recommended in pregnant women. Pregnant and breastfeeding women should consult with their doctors before taking this medicine.
Molvrio 200mg Capsule is the first oral antiviral medication that helps treat mild to moderate COVID-19 in adults. It prevents the virus from multiplying, thereby reducing viral load and disease severity. The drug received emergency use approval from Indian drug regulatory authorities on December 28, 2021.Molvrio 200mg Capsule is only indicated in patients with mild to moderate COVID-19 symptoms and who have a high risk of developing severe symptoms. The risk factors include obesity, older age (>60 years), diabetes mellitus, and heart diseases. It is not indicated in patients who require immediate hospitalization due to COVID-19. This drug has also been approved by the U.S. Food and Drug Administration (FDA) and the UK regulatory agency for emergency use.Molvrio 200mg Capsule should be taken orally for no longer than 5 consecutive days. It is important to complete the entire 5 days of treatment, therefore do not stop taking it even if you feel better. The medicine may cause dizziness, headache, diarrhea, and nausea in some patients. If one experiences any such side effects, discuss them with the doctor. They may help with the treatment or suggest ways to prevent them.Before taking Molvrio 200mg Capsule, let the doctor know if you have any pre-existing medical conditions. To make sure it is safe for you, inform your doctor about all the other medications you are taking. The use of Molvrio 200mg Capsule is not recommended in pregnant women. Pregnant and breastfeeding women should consult with their doctors before taking this medicine.
Take this medicine in the dose and duration as advised by your doctor. Molvrio 200mg Capsule may be taken with or without food, but it is better to take it at a fixed time.
If you miss a dose of Molvrio 200mg Capsule, please consult your doctor.
Prescription required. Upload a valid prescription at checkout or via prescription upload.
Our licensed pharmacists can help with availability, prescription verification, and ordering support.
Other medicines with a similar composition or name available on Vyloo. Always confirm therapeutic equivalence with your doctor or pharmacist before switching brands.
RxTorrent Pharmaceuticals Ltd · 10.0 capsules in 1 strip
RxTorrent Pharmaceuticals Ltd · 10.0 capsules in 1 strip
RxNatco Pharma Ltd · 40.0 capsules in 1 bottle
RxMylan Pharmaceuticals Pvt Ltd - A Viatris Company · 40.0 capsules in 1 bottle
RxVeritaz Healthcare Ltd · 10.0 capsules in 1 strip
RxOptimus Health Care · 10.0 tablets in 1 strip
RxSun Pharmaceutical Industries Ltd · 40.0 capsules in 1 bottle
RxJ B Chemicals and Pharmaceuticals Ltd · 10.0 capsules in 1 strip